These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2625323

  • 1. 17OH-progesterone response to acute dexamethasone administration in congenital adrenal hyperplasia.
    Shen SX, Young MC, Hinohosa-Sandoval M, Hughes IA.
    Horm Res; 1989; 32(4):136-41. PubMed ID: 2625323
    [Abstract] [Full Text] [Related]

  • 2. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA, Read GF.
    Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 4. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 5. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 6. Serum melatonin is not affected by glucocorticoid replacement in congenital adrenal hyperplasia.
    Waldhauser F, Frisch H, Krautgasser-Gasparotti A, Schober E, Bieglmayer C.
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):355-9. PubMed ID: 3962565
    [Abstract] [Full Text] [Related]

  • 7. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
    Horrocks PM, London DR.
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
    [Abstract] [Full Text] [Related]

  • 8. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [Abstract] [Full Text] [Related]

  • 9. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
    Sólyom J.
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
    [Abstract] [Full Text] [Related]

  • 10. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
    Richards GE, Grumbach MM, Kaplan SL, Conte FA.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
    [Abstract] [Full Text] [Related]

  • 11. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L.
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [Abstract] [Full Text] [Related]

  • 12. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B, Feuillan P, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [Abstract] [Full Text] [Related]

  • 13. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG, Sippell WG.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [Abstract] [Full Text] [Related]

  • 14. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
    Job JC, Munck A, Chaussain JL, Canlorbe P.
    Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
    [Abstract] [Full Text] [Related]

  • 16. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB.
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [Abstract] [Full Text] [Related]

  • 17. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone].
    Contreras P, Rojas A, Vega I.
    Rev Med Chil; 1989 Jun; 116(6):552-7. PubMed ID: 2749040
    [Abstract] [Full Text] [Related]

  • 18. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
    Pincus DR, Kelnar CJ, Wallace AM.
    J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous plasma and saliva steroid measurements as an index of control in congenital adrenal hyperplasia (CAH). A longitudinal study.
    Hughes IA, Read GF.
    Horm Res; 1982 Aug; 16(3):142-50. PubMed ID: 7106699
    [Abstract] [Full Text] [Related]

  • 20. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC, Hughes IA.
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.